Outsourcing Growth As a small biotechnology firm with a lean team and modest funding, Kalos Therapeutics is well positioned to scale through outsourced R&D services, CRO/CDMO partnerships, and contract manufacturing to advance its pipeline without significant in-house expansion.

Funding Partnerships With revenue present and external funding, the company may benefit from grant writing, non-dilutive funding strategies, and investor outreach, plus strategic partnerships with larger biotechs for co-development and milestone-based financing.

Digital Presence The current tech footprint suggests an older web stack. Offering modern website design, regulatory-ready marketing materials, search engine optimization, and analytics could improve credibility with partners and investors.

Regional Collaboration Located in San Diego, Kalos sits in a dense biotech ecosystem with potential regional partnerships, access to CROs, academic collaborators, and contract manufacturers. Targeted outreach to nearby companies and research institutions could yield pilots and collaborations.

Industry Alliances Pursuing licensing, co-development, or technology enablement partnerships with larger pharmaceutical companies can help accelerate programs, provide manufacturing scale, and expand access to resources.